465 related articles for article (PubMed ID: 12875710)
1. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
Wang Z; Liao Y; Dong J; Li S; Wang J; Fu ML
Chin Med J (Engl); 2003 Apr; 116(4):499-502. PubMed ID: 12875710
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
[TBL] [Abstract][Full Text] [Related]
3. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
Lauer B; Padberg K; Schultheiss HP; Strauer BE
Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303
[TBL] [Abstract][Full Text] [Related]
4. Prevention of myosin-induced autoimmune myocarditis in mice by anti-L3T4 monoclonal antibody.
Yuan HT; Liao YH; Wang Z; Dong JH; Cao LS; Wang ZH; Wang JP; Fu ML
Can J Physiol Pharmacol; 2003 Feb; 81(2):84-8. PubMed ID: 12710519
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis.
O'Donoghue HL; Lawson CM; Reed WD
Immunology; 1990 Sep; 71(1):20-8. PubMed ID: 2170269
[TBL] [Abstract][Full Text] [Related]
6. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
Blyszczuk P; Kania G; Dieterle T; Marty RR; Valaperti A; Berthonneche C; Pedrazzini T; Berger CT; Dirnhofer S; Matter CM; Penninger JM; Lüscher TF; Eriksson U
Circ Res; 2009 Oct; 105(9):912-20. PubMed ID: 19762681
[TBL] [Abstract][Full Text] [Related]
7. Anti-heart autoantibodies in familial dilated cardiomyopathy.
Caforio AL; Vinci A; Iliceto S
Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
[TBL] [Abstract][Full Text] [Related]
8. [Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses].
Caforio AL; Bonifacio E; Keeling PJ; Grazzini M; Schiaffino S; Bottazzo GF; McKenna WJ
G Ital Cardiol; 1992 Jan; 22(1):63-72. PubMed ID: 1624070
[TBL] [Abstract][Full Text] [Related]
9. [Cardiac impairments induced by adoptive transfer of lymphocytes from the experimental cardiomyopathy in mice].
Yuan J; Liao YH; Wang ZH; Zhang JH; Tian Y; Dong JH; Wang JP
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):892-6. PubMed ID: 16029527
[TBL] [Abstract][Full Text] [Related]
10. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
[TBL] [Abstract][Full Text] [Related]
11. Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome.
Morgun A; Shulzhenko N; Unterkircher CS; Diniz RV; Pereira AB; Silva MS; Nishida SK; Almeida DR; Carvalho AC; Franco M; Souza MM; Gerbase-DeLima M
J Heart Lung Transplant; 2004 Feb; 23(2):204-9. PubMed ID: 14761768
[TBL] [Abstract][Full Text] [Related]
12. Genetically determined myocarditis: clinical presentation and immunological characteristics.
Caforio AL; Iliceto S
Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.
Baldeviano GC; Barin JG; Talor MV; Srinivasan S; Bedja D; Zheng D; Gabrielson K; Iwakura Y; Rose NR; Cihakova D
Circ Res; 2010 May; 106(10):1646-55. PubMed ID: 20378858
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory dilated cardiomyopathy (DCMI).
Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
[TBL] [Abstract][Full Text] [Related]
15. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis.
Lawson CM; O'Donoghue HL; Reed WD
Immunology; 1992 Mar; 75(3):513-9. PubMed ID: 1315309
[TBL] [Abstract][Full Text] [Related]
16. [Effects of immunotherapy with anti-L3T4 monoclonal antibody on autoimmune cardiomyopathy: experiment with mice].
Yuan J; Liao YH; Wang ZH; Cheng X; Zhang JH; Dong JH; Wang M
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3346-9. PubMed ID: 16409842
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of myocarditis and dilated cardiomyopathy.
Cihakova D; Rose NR
Adv Immunol; 2008; 99():95-114. PubMed ID: 19117533
[TBL] [Abstract][Full Text] [Related]
18. Induction of antigen specific peripheral humoral tolerance to cardiac myosin does not prevent CB3-mediated autoimmune myocarditis.
Horwitz MS; Ilic A; Fine C; Sarvetnick N
J Autoimmun; 2005 Sep; 25(2):102-11. PubMed ID: 16011890
[TBL] [Abstract][Full Text] [Related]
19. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy.
Caforio AL; Mahon NJ; Mckenna WJ
Autoimmunity; 2001; 34(3):199-204. PubMed ID: 11908778
[TBL] [Abstract][Full Text] [Related]
20. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis.
Neumann DA; Rose NR; Ansari AA; Herskowitz A
J Immunol; 1994 Jan; 152(1):343-50. PubMed ID: 8254202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
